Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Evaxion Biotech's Cash Position Of $8M As Of June 30, 2024 Is Expected To Be Sufficient To Fund Its Operating Expenses And Capital Expenditure Requirements Into February 2025

Author: Benzinga Newsdesk | August 14, 2024 07:05am

Posted In: EVAX